MORE INFORMATION FROM ONE REACTION

• PCR kit detects and distinguishes Herpes Simplex Virus 1 and Herpes Simplex Virus 2 in a single reaction tube

EXCELLENT QUALITY

• The highest possible diagnostic sensitivity (100.00%) and diagnostic specificity (97.62%)

SIMPLE LABORATORY WORKFLOW

• Easily combinable with other GeneProof PCR kits in one workflow

DETECTION OF ALL HUMAN ADENOVIRUS SPECIES

The kit enables detection of Adenovirus respiratory species A–D, G and gastrointestinal species E-F

WIDE RANGE OF VALIDATED CLINICAL MATERIALS

• Validated specimen: aspirate, plasma, stool, swab, urine, whole blood
• Enables detection of both respiratory and gastrointestinal samples

Certificate: ROU 

Supplier: Illumina 

For Mid and Low-throughput laboratories performing COVID-19 surveillance and identification of new variants

As a product of Panagene (Korea), the PANAMAX ™ 48 automatic extraction device works on the principle of using lysis and binding of samples by magnetic particles. Along with 3 samples kit ready-for-use for the process of extracting DNA/RNA/ccfDNA, this is the solution automatically 100%, just adding the sample to the correct specified wells, the […]

The PANA RealTyper™ HPV Screening Kit is a CE marked diagnostic device in accordance with the European Union in vitro Diagnostic Medical Device Directive 98/79/EC

PANA RealTyper^TM HPV Kit is a CE marked diagnostic device in accordance with the European Union in vitro Diagnostic Medical Device Directive 98/79/EC.

The PANA RealTyper™ STD Kit is an in vitro diagnostic reagent for genotyping of 13 pathogens involved in sexually transmitted infections (STI) from vaginal swab and urine.

The PANA RealTyper™ STD Kit is a CE marked diagnostic device in accordance with the European Union in vitro Diagnostic Medical Device Directive 98/79/EC.

HBV (Hepatitis B Virus) is a dangerous virus that causes the disease of hepatitis B in humans. HBV is the second leading cause of cancer after smoking and is responsible for 60-80% of primary liver cancer cases and 50% of cases of cirrhosis. It is estimated that over 2 billion people worldwide have been or are currently infected with HBV, with approximately 400 million people being HBV carriers, of which 75% are from Asia. Every year, nearly 1 million people die from HBV-related illnesses such as cirrhosis and liver cancer.

Currently, HBV-DNA quantification is one of the important tests for evaluating the effectiveness of hepatitis B treatment and supporting physicians in deciding on treatment protocols.

GeneProof Hepatitis C Virus (HCV) PCR Kit uses PCR technology to detect HCV virus DNA present in patient samples.

CE-IVD Quality Certificate for Medical Diagnostic Use in vitro